Clinical trial
Insulin Glargine in Type 2 Diabetes Mellitus
NCT00272077 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00272077 |
|---|---|
| Title | Insulin Glargine in Type 2 Diabetes Mellitus |
| Official title | Pilot Study on Glycaemic Variability in Type 2 Diabetes Mellitus Patients With Basal Insulin and Fixed Combo Oral Antidiabetic Treatment. |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Insuline glargine |
| Start date | Apr 1, 2005 |
| Primary completion | May 1, 2006 |
| First posted | Jan 4, 2006 |
| Last update posted | Dec 7, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: